Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 9 2021

Full Issue

Biden Faces Crucial Choice Over Next FDA Chief

Stat analyzes the backgrounds and endorsements of the top two contenders on the list.

Stat: Dueling Endorsements Emerge For FDA Commissioner

As the White House struggles to address the pandemic and other pressing health matters, a public tug-of-war has emerged over who should be tapped to run the Food and Drug Administration. (Silverman, 2/8)

Stat: Woodcock Vs. Sharfstein: A Look At Biden’s Top Choices For FDA Chief

President Biden will soon have to nominate someone to helm the Food and Drug Administration. His two top contenders couldn’t have more divergent visions for how to lead that agency. (Florko, 2/9)

In other updates on President Biden's administration —

The Washington Post: Denis McDonough Confirmed As President Biden’s Veterans Affairs Chief

The Senate on Monday confirmed Denis McDonough as President Biden’s Veterans Affairs secretary, choosing a non-veteran but a manager with years of government service to lead the sprawling health and benefits agency. McDonough, 51, was chief of staff during Barack Obama’s second term and held senior roles on the National Security Council and on Capitol Hill before that. He told senators at his confirmation hearing that although he is not a veteran, his long career as a behind-the-scenes troubleshooter and policymaker would serve him well at the Department of Veterans Affairs, a massive bureaucracy beset by multiple challenges. (Rein, 2/8)

Politico: Buttigieg In Quarantine After Possible Covid Exposure 

DOT Secretary Pete Buttigieg is quarantining for the next 14 days after a member of his security detail tested positive for Covid-19.According to a press statement by DOT chief of staff Laura Schiller, the agent had been in close contact with Buttigieg, “including this morning prior to the agent’s positive result." (Snyder, 2/8)

The Washington Post: The Health 202: Andy Slavitt Wants To See Most Vaccines Get Administered Within A Week Of Shipping 

Andy Slavitt spent the first 10 months of the coronavirus pandemic as a private citizen. During that time he created the popular “In the Bubble” podcast about the virus and used it to raise money for relief efforts. But three weeks ago, the former Medicare and Medicaid chief became senior adviser to President Biden’s coronavirus response team, making him a key player in the federal government’s vaccine rollout as U.S. deaths near half a million. (Winfield Cunningham and Ellerbeck, 2/8)

Also —

The Hill: Biden Administration Sends Conflicting Signals On School Reopenings 

The Biden administration has sent conflicting signals about when and how to expect schools to reopen, with the White House at times appearing to downplay messaging from the Centers for Disease Control and Prevention (CDC). White House press secretary Jen Psaki has sought to minimize the scope of a CDC study that identified schools as low-transmission zones for the coronavirus and has brushed back CDC Director Rochelle Walensky for saying that the science supports the notion that teachers can return to classrooms before they’ve been vaccinated. (Easley and Parnes, 2/8)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF